Caption Management, LLC Seres Therapeutics, Inc. Transaction History

Caption Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$2.33 - $5.07 $17,735 - $38,592	7,612 New	7,612 $18,000
Q4 2021 Feb 11, 2022	SELL	$6.02 - $11.43 $19,565 - $37,147	-3,250 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$5.46 - $22.6 $325,885 - $1.35 Million	-59,686 Reduced 94.84%	3,250 $23,000
Q2 2021 Aug 16, 2021	BUY	$18.46 - $24.36 $423,398 - $558,720	22,936 Added 57.34%	62,936 $1.5 Million
Q2 2020 Aug 14, 2020	BUY	$3.04 - $6.2 $121,600 - $248,000	40,000 New	40,000 $191,000

40.5M

304K

471K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $114M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.